IGFBP3 and prostate carcinoma: However, in the current analysis there was an interaction of 25(OH)D and treatment arm among men with higher IGFBP-3, suggesting that 25(OH)D may increase the prostate cancer risk in men with higher levels of IGFBP-3 not receiving finasteride treatment.